Unbiased AI-powered news
3 stories related to this topic, newest first.
The IndependentA vaccine developed by Oxford University and Moderna will enter clinical testing this summer in patients with Lynch syndrome. The trial will assess whether the mRNA shot can train the immune system to destroy pre-cancerous cells before tumors form.
app.buzzsumo.comNewsweek reported that Moderna is involved in early-stage development of an mRNA vaccine targeting hantaviruses causing hemorrhagic fever with renal syndrome. The preclinical project, announced in 2024 by Korea University’s Vaccine Innovation Center, focuses on Asian strains and…
Moderna's mRNA-based seasonal flu vaccine proved 26.6 percent more effective than a conventional flu shot in a trial of more than 40,000 adults aged 50 and older. Results from the Phase 3 study were published Wednesday in the New England Journal of Medicine. The vaccine awaits a…